The	O
human	B-protein
T-cell	I-protein
leukemia	I-protein
virus	I-protein
type	I-protein
1	I-protein
posttranscriptional	I-protein
trans-activator	I-protein
Rex	B-protein
contains	O
a	O
nuclear	B-protein
export	I-protein
signal	I-protein
.	O

The	O
Rex	B-protein
protein	I-protein
of	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
is	O
required	O
for	O
the	O
nuclear	O
export	O
of	O
unspliced	B-RNA
viral	I-RNA
mRNA	I-RNA
and	O
,	O
therefore	O
,	O
for	O
virus	O
replication	O
.	O

In	O
this	O
manuscript	O
,	O
we	O
demonstrate	O
that	O
Rex	B-protein
shuttles	O
between	O
the	O
nucleus	O
and	O
the	O
cytoplasm	O
and	O
that	O
its	O
activation	B-protein
domain	I-protein
constitutes	O
a	O
nuclear	B-protein
export	I-protein
signal	I-protein
that	O
specifies	O
efficient	O
transport	O
to	O
the	O
cytoplasm	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
a	O
model	O
for	O
Rex	B-protein
-mediated	O
trans-activation	O
in	O
which	O
Rex-viral	B-protein
mRNA	I-protein
complexes	I-protein
are	O
targeted	O
for	O
nuclear	O
export	O
by	O
the	O
direct	O
action	O
of	O
the	O
activation	B-protein
domain	I-protein
.	O

JOURNAL	NULL
OF	NULL
ViroLOGY	NULL
,	NULL
Sept.	NULL
1996	NULL
,	NULL
p.	NULL
6442-6445	NULL
0022-538X	NULL
,	NULL
/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

70	NULL
,	NULL
No	NULL
.	NULL

9	NULL
The	NULL
Human	NULL
T-Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
1	NULL
Posttranscriptional	NULL
trans-Activator	NULL
Rex	NULL
Contains	NULL
a	NULL
Nuclear	NULL
Export	NULL
Signal	NULL
DIANA	NULL
PALMERTI	NULL
'	NULL
anp	NULL
MICHAEL	NULL
H.	NULL
MALIM®**	NULL
Graduate	NULL
Group	NULL
in	NULL
Molecular	NULL
Biology	NULL
,	NULL
}	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
``	NULL
and	NULL
Departments	NULL
of	NULL
Microbiology	NULL
and	NULL
Medicine	NULL
,	NULL
``	NULL
University	NULL
of	NULL
Pennsylvania	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Philadelphia	NULL
,	NULL
Pennsylvania	NULL
19104-6148	NULL
Received	NULL
22	NULL
February	NULL
1996/Accepted	NULL
16	NULL
May	NULL
1996	NULL
The	NULL
Rex	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
is	NULL
required	NULL
for	NULL
the	NULL
nuclear	NULL
export	NULL
of	NULL
unspliced	NULL
viral	NULL
mRNA	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
for	NULL
virus	NULL
replication	NULL
.	NULL

In	NULL
this	NULL
manuscript	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
Rex	NULL
shuttles	NULL
between	NULL
the	NULL
nucleus	NULL
and	NULL
the	NULL
cytoplasm	NULL
and	NULL
that	NULL
its	NULL
activation	NULL
domain	NULL
constitutes	NULL
a	NULL
nuclear	NULL
export	NULL
signal	NULL
that	NULL
specifies	NULL
efficient	NULL
transport	NULL
to	NULL
the	NULL
cytoplasm	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
for	NULL
Rex-mediated	NULL
frans-activation	NULL
in	NULL
which	NULL
Rex-viral	NULL
mRNA	NULL
complexes	NULL
are	NULL
targeted	NULL
for	NULL
nuclear	NULL
export	NULL
by	NULL
the	NULL
direct	NULL
action	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
and	NULL
HTLV-2	NULL
are	NULL
oncogenic	NULL
retroviruses	NULL
that	NULL
,	NULL
like	NULL
all	NULL
members	NULL
of	NULL
the	NULL
distantly	NULL
related	NULL
lentivirus	NULL
family	NULL
of	NULL
retroviruses	NULL
,	NULL
an	NULL
example	NULL
of	NULL
which	NULL
is	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
,	NULL
encode	NULL
proteins	NULL
that	NULL
posttranscriptionally	NULL
regulate	NULL
virus	NULL
gene	NULL
expression	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
principal	NULL
function	NULL
of	NULL
this	NULL
family	NULL
of	NULL
nuclear	NULL
trans-activator	NULL
proteins	NULL
,	NULL
termed	NULL
Rex	NULL
for	NULL
the	NULL
HTLVs	NULL
and	NULL
Rev	NULL
for	NULL
the	NULL
lentiviruses	NULL
,	NULL
is	NULL
to	NULL
activate	NULL
the	NULL
nuclear	NULL
export	NULL
of	NULL
unspliced	NULL
viral	NULL
mRNA	NULL
(	NULL
5	NULL
,	NULL
7	NULL
,	NULL
8	NULL
,	NULL
10	NULL
,	NULL
11	NULL
,	NULL
18	NULL
,	NULL
20	NULL
,	NULL
22	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Because	NULL
these	NULL
RNAs	NULL
serve	NULL
as	NULL
templates	NULL
for	NULL
virion	NULL
structural	NULL
protein	NULL
synthesis	NULL
(	NULL
namely	NULL
,	NULL
for	NULL
Gag	NULL
,	NULL
Pol	NULL
,	NULL
and	NULL
Env	NULL
)	NULL
and	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
full-length	NULL
primary	NULL
transcript	NULL
,	NULL
as	NULL
the	NULL
viral	NULL
genome	NULL
,	NULL
their	NULL
presence	NULL
in	NULL
the	NULL
cytoplasm	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
virus	NULL
replication	NULL
(	NULL
6	NULL
,	NULL
12	NULL
,	NULL
14	NULL
,	NULL
17	NULL
,	NULL
31	NULL
,	NULL
33	NULL
,	NULL
37	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
Rex	NULL
or	NULL
Rev	NULL
,	NULL
these	NULL
intron-containing	NULL
mRNAs	NULL
are	NULL
sequestered	NULL
by	NULL
the	NULL
nucleus	NULL
and	NULL
either	NULL
degraded	NULL
or	NULL
spliced	NULL
to	NULL
completion	NULL
(	NULL
7	NULL
,	NULL
11	NULL
,	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

The	NULL
domain	NULL
organization	NULL
of	NULL
the	NULL
~27-kDa	NULL
(	NULL
189-amino-acid	NULL
)	NULL
Rex	NULL
protein	NULL
of	NULL
HTLV-1	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

At	NULL
the	NULL
amino	NULL
terminus	NULL
is	NULL
a	NULL
19-amino-acid	NULL
arginine-rich	NULL
region	NULL
that	NULL
is	NULL
required	NULL
for	NULL
the	NULL
nuclear	NULL
accumulation	NULL
of	NULL
Rex	NULL
(	NULL
16	NULL
,	NULL
29	NULL
,	NULL
32	NULL
)	NULL
and	NULL
for	NULL
its	NULL
direct	NULL
interaction	NULL
with	NULL
its	NULL
cis-acting	NULL
RNA	NULL
target	NULL
,	NULL
the	NULL
Rex	NULL
response	NULL
element	NULL
(	NULL
1	NULL
,	NULL
3	NULL
,	NULL
11	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Toward	NULL
the	NULL
center	NULL
of	NULL
Rex	NULL
(	NULL
residues	NULL
79	NULL
to	NULL
99	NULL
)	NULL
there	NULL
is	NULL
a	NULL
second	NULL
domain	NULL
that	NULL
is	NULL
also	NULL
essential	NULL
for	NULL
biological	NULL
activity	NULL
(	NULL
4	NULL
,	NULL
13	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Because	NULL
experiments	NULL
performed	NULL
with	NULL
Rex-Rev	NULL
chimeric	NULL
proteins	NULL
have	NULL
demonstrated	NULL
that	NULL
this	NULL
21-amino-acid	NULL
segment	NULL
is	NULL
functionally	NULL
interchangeable	NULL
with	NULL
the	NULL
well-defined	NULL
activation	NULL
(	NULL
or	NULL
effector	NULL
)	NULL
domain	NULL
of	NULL
HIV-1	NULL
Rev	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
it	NULL
too	NULL
has	NULL
been	NULL
termed	NULL
the	NULL
activation	NULL
domain	NULL
(	NULL
13	NULL
,	NULL
39	NULL
)	NULL
.	NULL

As	NULL
can	NULL
be	NULL
visualized	NULL
from	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
Rex/Rev	NULL
activation	NULL
domains	NULL
are	NULL
characterized	NULL
by	NULL
their	NULL
possession	NULL
of	NULL
a	NULL
number	NULL
of	NULL
bulky	NULL
hydrophobic	NULL
residues	NULL
(	NULL
commonly	NULL
leucine	NULL
)	NULL
that	NULL
are	NULL
interspersed	NULL
with	NULL
more-hydrophilic	NULL
residues	NULL
.	NULL

It	NULL
is	NULL
widely	NULL
accepted	NULL
that	NULL
Rex/Rev	NULL
activation	NULL
domains	NULL
interact	NULL
with	NULL
host	NULL
cell	NULL
export	NULL
factors	NULL
(	NULL
proteins	NULL
)	NULL
such	NULL
that	NULL
unspliced	NULL
viral	NULL
mRNAs	NULL
that	NULL
are	NULL
bound	NULL
to	NULL
Rex	NULL
or	NULL
Rev	NULL
via	NULL
their	NULL
RNA	NULL
response	NULL
elements	NULL
can	NULL
be	NULL
transported	NULL
out	NULL
of	NULL
the	NULL
nucleus	NULL
(	NULL
2	NULL
,	NULL
9	NULL
,	NULL
25	NULL
,	NULL
30	NULL
,	NULL
35	NULL
)	NULL
;	NULL
a	NULL
failure	NULL
to	NULL
participate	NULL
in	NULL
such	NULL
interactions	NULL
presumably	NULL
results	NULL
in	NULL
a	NULL
loss	NULL
of	NULL
frans-activation	NULL
potential	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
found	NULL
that	NULL
the	NULL
Rev	NULL
activation	NULL
domains	NULL
of	NULL
HIV-1	NULL
,	NULL
visna	NULL
virus	NULL
,	NULL
and	NULL
equine	NULL
infectious	NULL
anemia	NULL
virus	NULL
are	NULL
potent	NULL
nuclear	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
215	NULL
)	NULL
573-3493	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
215	NULL
)	NULL
573-2172	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
malim	NULL
@	NULL
hmivax.humgen.upenn.edu	NULL
.	NULL

6442	NULL
export	NULL
signals	NULL
(	NULL
NESs	NULL
)	NULL
and	NULL
that	NULL
this	NULL
attribute	NULL
correlates	NULL
precisely	NULL
with	NULL
the	NULL
functionality	NULL
of	NULL
this	NULL
region	NULL
(	NULL
8	NULL
,	NULL
24	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Accord-ingly	NULL
,	NULL
it	NULL
has	NULL
been	NULL
noted	NULL
that	NULL
Rev	NULL
,	NULL
rather	NULL
than	NULL
being	NULL
confined	NULL
entirely	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
is	NULL
constitutively	NULL
cycling	NULL
(	NULL
shuttling	NULL
)	NULL
between	NULL
the	NULL
nucleus	NULL
and	NULL
the	NULL
cytoplasm	NULL
(	NULL
15	NULL
,	NULL
23	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
similarities	NULL
between	NULL
Rex	NULL
and	NULL
Rev	NULL
(	NULL
25	NULL
)	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
determine	NULL
(	NULL
i	NULL
)	NULL
whether	NULL
the	NULL
HTLV-1	NULL
Rex	NULL
frans-activator	NULL
is	NULL
a	NULL
nucleocytoplasmic	NULL
shuttle	NULL
protein	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
whether	NULL
its	NULL
activation	NULL
domain	NULL
can	NULL
function	NULL
as	NULL
a	NULL
NES	NULL
.	NULL

A	NULL
number	NULL
of	NULL
missense	NULL
mutations	NULL
were	NULL
therefore	NULL
introduced	NULL
into	NULL
the	NULL
Rex	NULL
activation	NULL
domain	NULL
of	NULL
the	NULL
peREX	NULL
expression	NULL
vector	NULL
(	NULL
11	NULL
)	NULL
.	NULL

These	NULL
substitutions	NULL
targeted	NULL
either	NULL
polar	NULL
(	NULL
glutamine	NULL
at	NULL
position	NULL
85	NULL
and	NULL
serine	NULL
at	NULL
position	NULL
91	NULL
)	NULL
or	NULL
hydrophobic	NULL
(	NULL
Jeucines	NULL
at	NULL
positions	NULL
86	NULL
and	NULL
90	NULL
)	NULL
residues	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
trans-activation	NULL
potential	NULL
of	NULL
each	NULL
mutant	NULL
protein	NULL
was	NULL
evaluated	NULL
by	NULL
a	NULL
previously	NULL
described	NULL
assay	NULL
in	NULL
which	NULL
COS	NULL
cells	NULL
are	NULL
transfected	NULL
with	NULL
a	NULL
genomic	NULL
version	NULL
of	NULL
the	NULL
HIV-1	NULL
tat	NULL
gene	NULL
that	NULL
harbors	NULL
the	NULL
Rex	NULL
response	NULL
element	NULL
within	NULL
its	NULL
intron	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
such	NULL
experi-ments	NULL
,	NULL
Rex	NULL
function	NULL
is	NULL
measured	NULL
by	NULL
the	NULL
induced	NULL
nuclear	NULL
export	NULL
of	NULL
unspliced	NULL
tat	NULL
mRNA	NULL
and	NULL
the	NULL
concomitant	NULL
synthesis	NULL
of	NULL
a	NULL
foreshortened	NULL
Tat	NULL
protein	NULL
comprising	NULL
72	NULL
amino	NULL
acids	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
with	NULL
this	NULL
set	NULL
of	NULL
mutant	NULL
Rex	NULL
proteins	NULL
are	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
;	NULL
specifically	NULL
,	NULL
of	NULL
the	NULL
four	NULL
activation	NULL
domain	NULL
mutants	NULL
tested	NULL
,	NULL
only	NULL
that	NULL
with	NULL
a	NULL
glutamine-to-alanine	NULL
mutation	NULL
at	NULL
position	NULL
85	NULL
(	NULL
Q85A¥	NULL
)	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
truncated	NULL
Tat	NULL
protein	NULL
.	NULL

Thus	NULL
,	NULL
as	NULL
has	NULL
been	NULL
noted	NULL
for	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
HIV-1	NULL
Rev	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
the	NULL
leucine	NULL
residues	NULL
of	NULL
the	NULL
HTLV-1	NULL
Rex	NULL
activation	NULL
domain	NULL
are	NULL
critical	NULL
for	NULL
biological	NULL
activity	NULL
whereas	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
other	NULL
residues	NULL
appears	NULL
to	NULL
be	NULL
less	NULL
important	NULL
.	NULL

However	NULL
,	NULL
and	NULL
in	NULL
contrast	NULL
to	NULL
HIV-1	NULL
Rev	NULL
,	NULL
the	NULL
«	NULL
-helix-breaking	NULL
amino	NULL
acid	NULL
proline	NULL
is	NULL
not	NULL
well	NULL
tolerated	NULL
by	NULL
the	NULL
Rex	NULL
activation	NULL
domain	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
nucleocytoplasmic	NULL
shuttling	NULL
capabilities	NULL
of	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
Rex	NULL
proteins	NULL
,	NULL
we	NULL
utilized	NULL
an	NULL
assay	NULL
whereby	NULL
the	NULL
sensitivity	NULL
of	NULL
nuclear	NULL
localization	NULL
to	NULL
the	NULL
transcriptional	NULL
status	NULL
of	NULL
the	NULL
cell	NULL
is	NULL
determined	NULL
(	NULL
23	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
proteins	NULL
that	NULL
shuttle	NULL
may	NULL
accumulate	NULL
in	NULL
the	NULL
cytoplasm	NULL
following	NULL
the	NULL
inhibition	NULL
of	NULL
transcription	NULL
whereas	NULL
proteins	NULL
that	NULL
do	NULL
not	NULL
cycle	NULL
remain	NULL
sequestered	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Although	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
this	NULL
effect	NULL
remains	NULL
an	NULL
enigma	NULL
,	NULL
it	NULL
is	NULL
presumably	NULL
due	NULL
to	NULL
the	NULL
efficiency	NULL
of	NULL
nuclear	NULL
import	NULL
being	NULL
dependent	NULL
on	NULL
ongoing	NULL
transcription	NULL
.	NULL

Duplicate	NULL
sets	NULL
of	NULL
HeLa	NULL
cell	NULL
monolayers	NULL
were	NULL
therefore	NULL
transfected	NULL
with	NULL
pcREX	NULL
and	NULL
the	NULL
Q85P	NULL
,	NULL
Q85A¥	NULL
,	NULL
S91P	NULL
,	NULL
and	NULL
L2+3A	NULL
mutant	NULL
expression	NULL
vectors	NULL
.	NULL

At	NULL
48	NULL
h	NULL
,	NULL
the	NULL
cultures	NULL
VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
NLS	NULL
&	NULL
activation	NULL
RNA	NULL
binding	NULL
domain	NULL
L	NULL
|__	NULL
|	NULL
1	NULL
189	NULL
/	NULL
\	NULL
biological	NULL
activity	NULL
:	NULL
Rexgvild	NULL
type	NULL
)	NULL
__	NULL
+	NULL
85P	NULL
an	NULL
_C	NULL
QB5A	NULL
a-	NULL
-+	NULL
S91P	NULL
\	NULL
.-..-._._L_.L___._	NULL
p	NULL
--	NULL
_	NULL
L2+3A	NULL
ae	NULL
--	NULL
A	NULL
--	NULL
-A	NULL
--	NULL
-	NULL
_	NULL
Rev	NULL
(	NULL
HIV-1	NULL
)	NULL
Rev	NULL
(	NULL
visna	NULL
virus	NULL
)	NULL
``	NULL
éyvaemEeNnLtL1*	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Mutagenesis	NULL
of	NULL
the	NULL
HTLV-1	NULL
Rex	NULL
activation	NULL
domain	NULL
.	NULL

The	NULL
region	NULL
of	NULL
Rex	NULL
that	NULL
harbors	NULL
the	NULL
nuclear	NULL
and	NULL
nucleolar	NULL
localization	NULL
signal	NULL
(	NULL
NLS	NULL
)	NULL
and	NULL
confers	NULL
RNA	NULL
(	NULL
Rex	NULL
response	NULL
element	NULL
)	NULL
binding	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
shaded	NULL
box	NULL
,	NULL
whereas	NULL
the	NULL
activation	NULL
domain	NULL
is	NULL
depicted	NULL
as	NULL
a	NULL
solid	NULL
box	NULL
.	NULL

The	NULL
primary	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
core	NULL
is	NULL
shown	NULL
below	NULL
along	NULL
with	NULL
the	NULL
missense	NULL
mutations	NULL
that	NULL
were	NULL
introduced	NULL
;	NULL
a	NULL
dash	NULL
indicates	NULL
that	NULL
no	NULL
alteration	NULL
was	NULL
made	NULL
at	NULL
that	NULL
position	NULL
.	NULL

The	NULL
biological	NULL
phenotype	NULL
of	NULL
each	NULL
Rex	NULL
protein	NULL
was	NULL
determined	NULL
with	NULL
the	NULL
pgTAT/RxRE	NULL
reporter	NULL
and	NULL
transiently	NULL
transfected	NULL
COS	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
to	NULL
activate	NULL
viral	NULL
mRNA	NULL
export	NULL
was	NULL
scored	NULL
as	NULL
the	NULL
induced	NULL
synthesis	NULL
of	NULL
the	NULL
72-amino-acid	NULL
Tat	NULL
protein	NULL
(	NULL
+	NULL
,	NULL
active	NULL
;	NULL
-	NULL
,	NULL
inactive	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
sequences	NULL
of	NULL
the	NULL
Rev	NULL
activation	NULL
domains	NULL
of	NULL
HIV-1	NULL
and	NULL
the	NULL
nonprimate	NULL
lentivirus	NULL
visna	NULL
virus	NULL
are	NULL
also	NULL
shown	NULL
;	NULL
the	NULL
mutationally	NULL
defined	NULL
three	NULL
essential	NULL
leucine	NULL
residues	NULL
of	NULL
the	NULL
HIV-1	NULL
Rev	NULL
activation	NULL
domain	NULL
(	NULL
21	NULL
)	NULL
are	NULL
highlighted	NULL
with	NULL
shaded	NULL
boxes	NULL
.	NULL

were	NULL
transferred	NULL
to	NULL
medium	NULL
supplemented	NULL
with	NULL
50	NULL
pg	NULL
of	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
cycloheximide	NULL
per	NULL
ml	NULL
.	NULL

After	NULL
30	NULL
min	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
actinomycin	NULL
D	NULL
per	NULL
ml	NULL
was	NULL
added	NULL
to	NULL
one	NULL
set	NULL
of	NULL
cultures	NULL
while	NULL
the	NULL
other	NULL
set	NULL
remained	NULL
in	NULL
cycloheximide-containing	NULL
me-dium	NULL
.	NULL

The	NULL
inclusion	NULL
of	NULL
an	NULL
inhibitor	NULL
of	NULL
protein	NULL
synthesis	NULL
in	NULL
these	NULL
experiments	NULL
was	NULL
critical	NULL
,	NULL
as	NULL
it	NULL
ensured	NULL
that	NULL
the	NULL
Rex	NULL
proteins	NULL
being	NULL
examined	NULL
were	NULL
nuclear	NULL
at	NULL
the	NULL
time	NULL
of	NULL
actinomycin	NULL
D	NULL
addition	NULL
.	NULL

After	NULL
a	NULL
further	NULL
2.5-h	NULL
incubation	NULL
,	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
each	NULL
Rex	NULL
protein	NULL
was	NULL
determined	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
using	NULL
a	NULL
Rex-specific	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
(	NULL
3	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
reports	NULL
,	NULL
wild-type	NULL
Rex	NULL
as	NULL
well	NULL
as	NULL
the	NULL
four	NULL
mutants	NULL
all	NULL
localized	NULL
to	NULL
the	NULL
nuclei	NULL
of	NULL
transcriptionally	NULL
active	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
,	NULL
c	NULL
,	NULL
e	NULL
,	NULL
g	NULL
,	NULL
and	NULL
i	NULL
)	NULL
(	NULL
16	NULL
,	NULL
29	NULL
,	NULL
32	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
both	NULL
wild-type	NULL
Rex	NULL
and	NULL
the	NULL
Q85A	NULL
mutant	NULL
relocated	NULL
to	NULL
the	NULL
cytoplasm	NULL
to	NULL
a	NULL
significant	NULL
degree	NULL
following	NULL
transcriptional	NULL
inhibition	NULL
(	NULL
Fig	NULL
.	NULL

2b	NULL
and	NULL
f	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
strongly	NULL
suggests	NULL
that	NULL
QB5P	NULL
-	NULL
Act	NULL
D	NULL
NOTES	NULL
6443	NULL
=	NULL
Act	NULL
D	NULL
+	NULL
ActD	NULL
o	NULL
-	NULL
Rex	NULL
«	NULL
-	NULL
hnRNP	NULL
C	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Subcellular	NULL
localization	NULL
of	NULL
Rex	NULL
in	NULL
HTLV-1-infected	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proliferating	NULL
HUT102	NULL
cells	NULL
(	NULL
a	NULL
and	NULL
b	NULL
)	NULL
or	NULL
cultures	NULL
that	NULL
had	NULL
been	NULL
treated	NULL
with	NULL
cycloheximide	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
actinomycin	NULL
D	NULL
plus	NULL
cycloheximide	NULL
for	NULL
2.5	NULL
h	NULL
(	NULL
c	NULL
and	NULL
d	NULL
)	NULL
were	NULL
adhered	NULL
to	NULL
glass	NULL
coverslips	NULL
by	NULL
centrifugation	NULL
at	NULL
400	NULL
X	NULL
g	NULL
for	NULL
5	NULL
min	NULL
with	NULL
a	NULL
Cytospin	NULL
apparatus	NULL
.	NULL

Fixed	NULL
cells	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
double-label	NULL
immunofluorescence	NULL
with	NULL
primary	NULL
antibodies	NULL
specific	NULL
for	NULL
Rex	NULL
(	NULL
a	NULL
and	NULL
c	NULL
)	NULL
or	NULL
the	NULL
heterogeneous	NULL
ribonucleoprotein	NULL
C1	NULL
and	NULL
C2	NULL
proteins	NULL
(	NULL
b	NULL
and	NULL
d	NULL
)	NULL
.	NULL

these	NULL
two	NULL
proteins	NULL
,	NULL
both	NULL
of	NULL
which	NULL
activate	NULL
viral	NULL
mRNA	NULL
export	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
are	NULL
able	NULL
to	NULL
shuttle	NULL
between	NULL
the	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
the	NULL
correlation	NULL
between	NULL
biological	NULL
activity	NULL
and	NULL
activation	NULL
domain-determined	NULL
nuclear	NULL
export	NULL
,	NULL
the	NULL
nonfunc-tional	NULL
Q85P	NULL
,	NULL
S91P	NULL
,	NULL
and	NULL
L2+3A	NULL
mutants	NULL
each	NULL
remained	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
Fig	NULL
.	NULL

2d	NULL
,	NULL
h	NULL
,	NULL
and	NULL
j	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
whereas	NULL
these	NULL
mutants	NULL
displayed	NULL
similar	NULL
nuclear	NULL
staining	NULL
patterns	NULL
in	NULL
treated	NULL
and	NULL
untreated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
compare	NULL
panels	NULL
c	NULL
,	NULL
g	NULL
,	NULL
and	NULL
i	NULL
with	NULL
panels	NULL
d	NULL
,	NULL
h	NULL
,	NULL
and	NULL
j	NULL
)	NULL
,	NULL
the	NULL
exported	NULL
wild-type	NULL
and	NULL
Q85A	NULL
proteins	NULL
became	NULL
more	NULL
evenly	NULL
distributed	NULL
within	NULL
the	NULL
nuclei	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
actinomycin	NULL
D	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
compare	NULL
panels	NULL
a	NULL
and	NULL
e	NULL
with	NULL
panels	NULL
b	NULL
and	NULL
f	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
Rex	NULL
shuttles	NULL
in	NULL
virally	NULL
infected	NULL
cells	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
transcription	NULL
inhibition	NULL
on	NULL
the	NULL
subcellular	NULL
distribution	NULL
of	NULL
Rex	NULL
in	NULL
the	NULL
HTLV-1-producing	NULL
human	NULL
T-cell	NULL
line	NULL
HUT102	NULL
was	NULL
determined	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
(	NULL
27	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
nuclear	NULL
integrity	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
also	NULL
stained	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
specific	NULL
for	NULL
the	NULL
heterogeneous	NULL
nuclear	NULL
ribonucleoprotein	NULL
particle	NULL
C1	NULL
and	NULL
C2	NULL
proteins	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Rex	NULL
was	NULL
visualized	NULL
as	NULL
before	NULL
,	NULL
with	NULL
a	NULL
Texas	NULL
red-conjugated	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
and	NULL
c	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
C1	NULL
QB5A	NULL
S91P	NULL
L2+3A	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

The	NULL
nuclear	NULL
export	NULL
of	NULL
Rex	NULL
is	NULL
dependent	NULL
on	NULL
a	NULL
functional	NULL
activation	NULL
domain	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
seeded	NULL
onto	NULL
glass	NULL
coverslips	NULL
at	NULL
a	NULL
density	NULL
of	NULL
2.5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
35-mm-diameter	NULL
dish	NULL
.	NULL

Duplicate	NULL
monolayers	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
pg	NULL
of	NULL
peREX	NULL
or	NULL
each	NULL
one	NULL
of	NULL
the	NULL
four	NULL
mutant	NULL
activation	NULL
domain	NULL
derivatives	NULL
.	NULL

At	NULL
~48	NULL
h	NULL
,	NULL
the	NULL
cultures	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
containing	NULL
either	NULL
50	NULL
ug	NULL
of	NULL
cycloheximide	NULL
per	NULL
ml	NULL
(	NULL
a	NULL
,	NULL
c	NULL
,	NULL
e	NULL
,	NULL
g	NULL
,	NULL
and	NULL
i	NULL
)	NULL
or	NULL
cycloheximide	NULL
plus	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
transcription	NULL
inhibitor	NULL
actinomycin	NULL
D	NULL
per	NULL
ml	NULL
(	NULL
b	NULL
,	NULL
d	NULL
,	NULL
f	NULL
,	NULL
h	NULL
,	NULL
and	NULL
j	NULL
)	NULL
.	NULL

Following	NULL
fixation	NULL
,	NULL
the	NULL
subcellular	NULL
localization	NULL
patterns	NULL
of	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
Rex	NULL
proteins	NULL
were	NULL
determined	NULL
with	NULL
a	NULL
Rex-specific	NULL
antiserum	NULL
raised	NULL
in	NULL
a	NULL
rabbit	NULL
and	NULL
a	NULL
Texas	NULL
red-conjugated	NULL
anti-rabbit	NULL
secondary	NULL
antibody	NULL
.	NULL

All	NULL
samples	NULL
were	NULL
viewed	NULL
by	NULL
epifluorescence	NULL
(	NULL
23	NULL
)	NULL
.	NULL

6444	NULL
NOTES	NULL
GST	NULL
:	NULL
Rex	NULL
wild	NULL
type	NULL
GST	NULL
:	NULL
Q85P	NULL
-	NULL
GST	NULL
GST	NULL
:	NULL
Q85A	NULL
J.	NULL
ViRoL	NULL
.	NULL

GST	NULL
:	NULL
S91P	NULL
GST	NULL
:	NULL
L2+3A	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

The	NULL
activation	NULL
domain	NULL
of	NULL
Rex	NULL
is	NULL
a	NULL
potent	NULL
nuclear	NULL
export	NULL
signal	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
seeded	NULL
onto	NULL
glass	NULL
coverslips	NULL
and	NULL
injected	NULL
into	NULL
the	NULL
nucleus	NULL
with	NULL
mixtures	NULL
of	NULL
rabbit	NULL
IgG	NULL
and	NULL
GST-Rex	NULL
fusion	NULL
proteins	NULL
.	NULL

Following	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
fixed	NULL
and	NULL
subjected	NULL
to	NULL
double-label	NULL
indirect	NULL
immunofluorescence	NULL
.	NULL

The	NULL
GST-Rex	NULL
proteins	NULL
were	NULL
visualized	NULL
in	NULL
two	NULL
steps	NULL
by	NULL
using	NULL
a	NULL
GST	NULL
-specific	NULL
monoclonal	NULL
antibody	NULL
followed	NULL
by	NULL
a	NULL
Texas	NULL
red-conjugated	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
a	NULL
,	NULL
c	NULL
,	NULL
¢	NULL
,	NULL
g	NULL
,	NULL
and	NULL
i	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
IgG	NULL
was	NULL
detected	NULL
in	NULL
a	NULL
single	NULL
step	NULL
by	NULL
using	NULL
a	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
anti-rabbit	NULL
antibody	NULL
(	NULL
b	NULL
,	NULL
d	NULL
,	NULL
f	NULL
,	NULL
h	NULL
,	NULL
and	NULL
j	NULL
)	NULL
.	NULL

and	NULL
C2	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
a	NULL
goat	NULL
anti-mouse	NULL
antibody	NULL
conjugated	NULL
to	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
and	NULL
d	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
,	NULL
Rex	NULL
is	NULL
clearly	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
of	NULL
these	NULL
infected	NULL
T	NULL
cells	NULL
at	NULL
the	NULL
steady	NULL
state	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
and	NULL
consistent	NULL
with	NULL
what	NULL
was	NULL
observed	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
a	NULL
clear	NULL
redistribution	NULL
of	NULL
Rex	NULL
to	NULL
the	NULL
cytoplasm	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
5	NULL
pg	NULL
of	NULL
actinomycin	NULL
D	NULL
per	NULL
ml	NULL
for	NULL
2.5	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3¢	NULL
)	NULL
.	NULL

As	NULL
an	NULL
independent	NULL
verification	NULL
of	NULL
its	NULL
classification	NULL
as	NULL
a	NULL
shuttle	NULL
protein	NULL
,	NULL
we	NULL
also	NULL
found	NULL
that	NULL
Rex	NULL
can	NULL
migrate	NULL
from	NULL
one	NULL
nucleus	NULL
to	NULL
another	NULL
in	NULL
the	NULL
context	NULL
of	NULL
interspecies	NULL
heterokaryons	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
data	NULL
to	NULL
this	NULL
point	NULL
imply	NULL
that	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
Rex	NULL
can	NULL
function	NULL
as	NULL
a	NULL
NES	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
directly	NULL
,	NULL
residues	NULL
78	NULL
to	NULL
96	NULL
of	NULL
wild-type	NULL
Rex	NULL
and	NULL
the	NULL
Q85P	NULL
,	NULL
Q85A	NULL
,	NULL
S91P	NULL
,	NULL
and	NULL
L2+3A	NULL
mutants	NULL
were	NULL
appended	NULL
to	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
(	NULL
24	NULL
)	NULL
.	NULL

These	NULL
five	NULL
GST	NULL
-Rex	NULL
fusion	NULL
proteins	NULL
were	NULL
purified	NULL
from	NULL
Escherichia	NULL
coli	NULL
by	NULL
affinity	NULL
chromatography	NULL
using	NULL
glutathione-Sepharose	NULL
4B	NULL
,	NULL
concentrated	NULL
to	NULL
~8	NULL
mg/ml	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
micro-injected	NULL
into	NULL
the	NULL
nuclei	NULL
of	NULL
living	NULL
HeLa	NULL
cells	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
site	NULL
of	NULL
injection	NULL
was	NULL
established	NULL
by	NULL
supplementing	NULL
the	NULL
GST-Rex	NULL
preparations	NULL
with	NULL
rabbit	NULL
immunoglobulin	NULL
G	NULL
(	NULL
IgG	NULL
)	NULL
(	NULL
24	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Following	NULL
a	NULL
30-min	NULL
incubation	NULL
at	NULL
37°C	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
each	NULL
Rex	NULL
fusion	NULL
protein	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
cytoplasm	NULL
was	NULL
assessed	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
GST	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
a	NULL
GST	NULL
-specific	NULL
monoclonal	NULL
antibody	NULL
followed	NULL
by	NULL
a	NULL
Texas	NULL
red-conjugated	NULL
goat	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
,	NULL
c	NULL
,	NULL
e	NULL
,	NULL
g	NULL
,	NULL
and	NULL
i	NULL
)	NULL
,	NULL
while	NULL
the	NULL
rabbit	NULL
IgG	NULL
was	NULL
visualized	NULL
with	NULL
a	NULL
goat	NULL
anti-rabbit	NULL
antibody	NULL
conjugated	NULL
to	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
,	NULL
d	NULL
,	NULL
f	NULL
,	NULL
h	NULL
,	NULL
and	NULL
j	NULL
)	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Strikingly	NULL
,	NULL
whereas	NULL
the	NULL
IgG	NULL
always	NULL
remained	NULL
nuclear	NULL
,	NULL
the	NULL
GST	NULL
-Rex	NULL
wild-type	NULL
fusion	NULL
protein	NULL
had	NULL
relocated	NULL
to	NULL
the	NULL
cytoplasm	NULL
to	NULL
apparent	NULL
entirety	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

The	NULL
only	NULL
other	NULL
protein	NULL
that	NULL
displayed	NULL
this	NULL
phenotype	NULL
was	NULL
the	NULL
one	NULL
that	NULL
harbored	NULL
a	NULL
functional	NULL
activation	NULL
domain	NULL
,	NULL
namely	NULL
GST-Q85A	NULL
(	NULL
Fig	NULL
.	NULL

4e	NULL
)	NULL
.	NULL

All	NULL
three	NULL
GST	NULL
fusions	NULL
that	NULL
carried	NULL
inactive	NULL
activation	NULL
domains	NULL
remained	NULL
confined	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

4c	NULL
,	NULL
g	NULL
,	NULL
and	NULL
i	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
not	NULL
only	NULL
can	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
Rex	NULL
act	NULL
as	NULL
an	NULL
autonomous	NULL
and	NULL
transferable	NULL
NES	NULL
,	NULL
but	NULL
it	NULL
also	NULL
does	NULL
so	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
correlates	NULL
with	NULL
its	NULL
frans-activation	NULL
potential	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
Rex	NULL
trans-activator	NULL
of	NULL
HTLV-1	NULL
is	NULL
,	NULL
like	NULL
HIV-1	NULL
Rev	NULL
,	NULL
a	NULL
nucleocytoplasmic	NULL
shuttle	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Using	NULL
mutant	NULL
Rex	NULL
proteins	NULL
that	NULL
carry	NULL
disruptions	NULL
of	NULL
the	NULL
activation	NULL
domain	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
capacity	NULL
of	NULL
Rex	NULL
to	NULL
accumulate	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
response	NULL
to	NULL
transcriptional	NULL
inhibition	NULL
is	NULL
always	NULL
matched	NULL
with	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
viral	NULL
mRNA	NULL
export	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
all	NULL
biologically	NULL
active	NULL
Rex	NULL
activation	NULL
domains	NULL
function	NULL
as	NULL
autonomous	NULL
and	NULL
transferable	NULL
NESs	NULL
whereas	NULL
inactive	NULL
variants	NULL
do	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Given	NULL
that	NULL
these	NULL
same	NULL
correlations	NULL
also	NULL
hold	NULL
true	NULL
for	NULL
the	NULL
HIV-1	NULL
Rev	NULL
protein	NULL
,	NULL
our	NULL
data	NULL
therefore	NULL
lend	NULL
further	NULL
support	NULL
to	NULL
the	NULL
notion	NULL
that	NULL
Rex	NULL
and	NULL
Rev	NULL
activate	NULL
viral	NULL
mRNA	NULL
transport	NULL
by	NULL
a	NULL
shared	NULL
mechanism	NULL
.	NULL

Specifically	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
the	NULL
activation	NULL
domains	NULL
of	NULL
these	NULL
proteins	NULL
constitute	NULL
the	NULL
NESs	NULL
that	NULL
target	NULL
nuclear	NULL
Rex/Rev-viral	NULL
mRNA	NULL
complexes	NULL
for	NULL
transport	NULL
to	NULL
the	NULL
cytoplasm	NULL
.	NULL

While	NULL
these	NULL
studies	NULL
were	NULL
being	NULL
carried	NULL
out	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
by	NULL
others	NULL
that	NULL
actinomycin	NULL
D	NULL
treatment	NULL
induces	NULL
a	NULL
relocaliza-tion	NULL
of	NULL
Rex	NULL
to	NULL
the	NULL
cytoplasm	NULL
of	NULL
transfected	NULL
HeLa	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

We	NULL
thank	NULL
Barbara	NULL
Meyer	NULL
,	NULL
Bryan	NULL
Cullen	NULL
,	NULL
and	NULL
Hal	NULL
Bogerd	NULL
for	NULL
many	NULL
helpful	NULL
discussions	NULL
and	NULL
Laurie	NULL
Zimmerman	NULL
for	NULL
secretarial	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
and	NULL
a	NULL
Minority	NULL
Predoctoral	NULL
Fellowship	NULL
(	NULL
5-F31-HG-00065	NULL
)	NULL
from	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
General	NULL
Medical	NULL
Sciences	NULL
to	NULL
D.P	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ballaun	NULL
,	NULL
C.	NULL
,	NULL
G.	NULL
K.	NULL
Farrington	NULL
,	NULL
M.	NULL
Dobrovaik	NULL
,	NULL
J.	NULL
Rusche	NULL
,	NULL
J.	NULL
Hauber	NULL
,	NULL
and	NULL
E.	NULL
Bohnlein	NULL
.	NULL

1991	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
rex-response	NULL
element	NULL
:	NULL
direct	NULL
RNA	NULL
binding	NULL
of	NULL
Rex	NULL
protein	NULL
correlates	NULL
with	NULL
in	NULL
vivo	NULL
activity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

6514408-4413	NULL
.	NULL

2	NULL
.	NULL

Bogerd	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
R.	NULL
A.	NULL
Fridell	NULL
,	NULL
S.	NULL
Madore	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Cullen	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
novel	NULL
cellular	NULL
cofactor	NULL
for	NULL
the	NULL
Rev/Rex	NULL
class	NULL
of	NULL
retroviral	NULL
regulatory	NULL
proteins	NULL
.	NULL

Cell	NULL
82:485-494	NULL
.	NULL

3	NULL
.	NULL

Bogerd	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
G.	NULL
L.	NULL
Huckaby	NULL
,	NULL
Y.	NULL
F.	NULL
Ahmed	NULL
,	NULL
S.	NULL
M.	NULL
Hanly	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
type	NULL
I	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-I	NULL
)	NULL
Rex	NULL
trans-activator	NULL
binds	NULL
directly	NULL
to	NULL
the	NULL
HTLV-I	NULL
Rex	NULL
and	NULL
the	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
Rev	NULL
RNA	NULL
response	NULL
elements	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:5704-5708	NULL
.	NULL

4	NULL
.	NULL

Bohnlein	NULL
,	NULL
S.	NULL
,	NULL
F.	NULL
P.	NULL
Pirker	NULL
,	NULL
L.	NULL
Hoger	NULL
,	NULL
K.	NULL
Zimmermann	NULL
,	NULL
H.	NULL
Bachmayer	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
J.	NULL
Hauber	NULL
.	NULL

1991	NULL
.	NULL

Transdominant	NULL
repressors	NULL
for	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Rex	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Rev	NULL
function	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:81-88	NULL
.	NULL

5	NULL
.	NULL

Emerman	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Vazeux	NULL
,	NULL
and	NULL
K.	NULL
Peden	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
rev	NULL
gene	NULL
product	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
affects	NULL
envelope-specific	NULL
RNA	NULL
localization	NULL
.	NULL

Cell	NULL
57:1155-1165	NULL
.	NULL

6	NULL
.	NULL

Feinberg	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
R.	NULL
F.	NULL
Jarrett	NULL
,	NULL
A.	NULL
Aldovini	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
F.	NULL
Wong-Staal	NULL
.	NULL

1986	NULL
.	NULL

HTLV-III	NULL
expression	NULL
and	NULL
production	NULL
involve	NULL
complex	NULL
regulation	NULL
at	NULL
the	NULL
levels	NULL
of	NULL
splicing	NULL
and	NULL
translation	NULL
of	NULL
viral	NULL
RNA	NULL
.	NULL

Cell	NULL
46:807-817	NULL
.	NULL

7	NULL
.	NULL

Felber	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
M.	NULL
Hadzopoulou-Cladaras	NULL
,	NULL
C.	NULL
Cladaras	NULL
,	NULL
T.	NULL
Copeland	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Pavlakis	NULL
.	NULL

1989	NULL
.	NULL

Rev	NULL
protein	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
affects	NULL
the	NULL
stability	NULL
and	NULL
transport	NULL
of	NULL
the	NULL
viral	NULL
mRNA	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:1495-1499	NULL
.	NULL

VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
8	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

Fischer	NULL
,	NULL
U.	NULL
,	NULL
J.	NULL
Huber	NULL
,	NULL
W.	NULL
C.	NULL
Boelens	NULL
,	NULL
I.	NULL
W.	NULL
Mattaj	NULL
,	NULL
and	NULL
R.	NULL
Liihrmann	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
HIV-1	NULL
Rev	NULL
activation	NULL
domain	NULL
is	NULL
a	NULL
nuclear	NULL
export	NULL
signal	NULL
that	NULL
accesses	NULL
an	NULL
export	NULL
pathway	NULL
used	NULL
by	NULL
specific	NULL
cellular	NULL
RNAs	NULL
.	NULL

Cell	NULL
82:475-483.	NULL
.	NULL

Fritz	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
M.	NULL
L.	NULL
Zapp	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
human	NULL
nucleoporin-like	NULL
protein	NULL
that	NULL
specifically	NULL
interacts	NULL
with	NULL
HIV	NULL
Rev	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
376:530-533	NULL
.	NULL

Hammarskjold	NULL
,	NULL
M.-L.	NULL
,	NULL
J.	NULL
Heimer	NULL
,	NULL
B.	NULL
Hammarskjold	NULL
,	NULL
I.	NULL
Sangwan	NULL
,	NULL
L.	NULL
Albert	NULL
,	NULL
and	NULL
D.	NULL
Rekosh	NULL
.	NULL

1989	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
env	NULL
expression	NULL
by	NULL
the	NULL
rev	NULL
gene	NULL
product	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:1959-1966	NULL
.	NULL

Hanly	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
L.	NULL
T.	NULL
Rimsky	NULL
,	NULL
M.	NULL
H.	NULL
Malim	NULL
,	NULL
J.	NULL
H.	NULL
Kim	NULL
,	NULL
J.	NULL
Hauber	NULL
,	NULL
M.	NULL
Duc	NULL
Dodon	NULL
,	NULL
S.-Y	NULL
.	NULL

Le	NULL
,	NULL
J.	NULL
V.	NULL
Maizel	NULL
,	NULL
B.	NULL
R.	NULL
Cullen	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Comparative	NULL
analysis	NULL
of	NULL
the	NULL
HTLV-I	NULL
Rex	NULL
and	NULL
HIV-1	NULL
Rev	NULL
frans-regulatory	NULL
proteins	NULL
and	NULL
their	NULL
RNA	NULL
response	NULL
elements	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1534-1544	NULL
.	NULL

Hidaka	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Inoue	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1988	NULL
.	NULL

Post-transcriptional	NULL
regulator	NULL
(	NULL
rex	NULL
)	NULL
of	NULL
HTLV-1	NULL
initiates	NULL
expression	NULL
of	NULL
viral	NULL
structural	NULL
proteins	NULL
but	NULL
suppresses	NULL
expression	NULL
of	NULL
regulatory	NULL
proteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:519-523	NULL
.	NULL

Hope	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
B.	NULL
L.	NULL
Bond	NULL
,	NULL
D.	NULL
McDonald	NULL
,	NULL
N.	NULL
P.	NULL
Klein	NULL
,	NULL
and	NULL
T.	NULL
G.	NULL
Parslow	NULL
.	NULL

1991	NULL
.	NULL

Effector	NULL
domains	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Rev	NULL
and	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Rex	NULL
are	NULL
functionally	NULL
interchangeable	NULL
and	NULL
share	NULL
an	NULL
essential	NULL
peptide	NULL
motif	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:6001-6007	NULL
.	NULL

Inoue	NULL
,	NULL
J.-L.	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1987	NULL
.	NULL

Transcriptional	NULL
(	NULL
p40	NULL
``	NULL
)	NULL
and	NULL
post-transcriptional	NULL
(	NULL
p27*	NULL
``	NULL
``	NULL
``	NULL
)	NULL
regulators	NULL
are	NULL
required	NULL
for	NULL
the	NULL
expression	NULL
and	NULL
replication	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
genes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:3653-3657	NULL
.	NULL

Kalland	NULL
,	NULL
K.-H.	NULL
,	NULL
A.	NULL
M.	NULL
Szilvay	NULL
,	NULL
K.	NULL
A.	NULL
Brokstad	NULL
,	NULL
W.	NULL
Sactrevik	NULL
,	NULL
and	NULL
G.	NULL
Hauke-nes	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Rev	NULL
protein	NULL
shuttles	NULL
between	NULL
the	NULL
cytoplasm	NULL
and	NULL
nuclear	NULL
compartments	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7436-7444	NULL
.	NULL

Kiyokawa	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
S.	NULL
Iwashita	NULL
,	NULL
K.	NULL
Imagawa	NULL
,	NULL
F.	NULL
Shimizu	NULL
,	NULL
and	NULL
M.	NULL
Yo-shida	NULL
.	NULL

1985.	NULL
p**	NULL
``	NULL
and	NULL
p*	NULL
``	NULL
,	NULL
proteins	NULL
encoded	NULL
by	NULL
the	NULL
pX	NULL
sequence	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:8359-8363	NULL
.	NULL

Kiyomasu	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Miyazawa	NULL
,	NULL
T.	NULL
Furuya	NULL
,	NULL
R.	NULL
Shibata	NULL
,	NULL
H.	NULL
Sakai	NULL
,	NULL
J.-L.	NULL
Sakuragi	NULL
,	NULL
M.	NULL
Fukasawa	NULL
,	NULL
N.	NULL
Maki	NULL
,	NULL
A.	NULL
Hasegawa	NULL
,	NULL
T.	NULL
Mikami	NULL
,	NULL
and	NULL
A.	NULL
Adachi	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
feline	NULL
immunodeficiency	NULL
virus	NULL
rev	NULL
gene	NULL
activity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:4539-4542	NULL
.	NULL

Malim	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
S.	NULL
Bohnlein	NULL
,	NULL
R.	NULL
Fenrick	NULL
,	NULL
S.-Y	NULL
.	NULL

Le	NULL
,	NULL
J.	NULL
V.	NULL
Maizel	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Cullen	NULL
.	NULL

1989	NULL
.	NULL

Functional	NULL
comparison	NULL
of	NULL
the	NULL
Rev	NULL
trans-activators	NULL
encoded	NULL
by	NULL
different	NULL
primate	NULL
immunodeficiency	NULL
virus	NULL
species	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:8222-8226	NULL
.	NULL

Malim	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Cullen	NULL
.	NULL

1993	NULL
.	NULL

Rev	NULL
and	NULL
the	NULL
fate	NULL
of	NULL
pre-mRNA	NULL
in	NULL
the	NULL
nucleus	NULL
:	NULL
implications	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
RNA	NULL
processing	NULL
in	NULL
eukaryotes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6180-6189	NULL
.	NULL

Malim	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
J.	NULL
Hauber	NULL
,	NULL
S.-Y	NULL
.	NULL

Le	NULL
,	NULL
J.	NULL
V.	NULL
Maizel	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Cullen	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
HIV-1	NULL
rev	NULL
frans-activator	NULL
acts	NULL
through	NULL
a	NULL
structured	NULL
target	NULL
sequence	NULL
to	NULL
activate	NULL
nuclear	NULL
export	NULL
of	NULL
unspliced	NULL
viral	NULL
mRNA	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
338:254-257	NULL
.	NULL

Malim	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
D.	NULL
F.	NULL
McCarn	NULL
,	NULL
L.	NULL
S.	NULL
Tiley	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Cullen	NULL
.	NULL

1991	NULL
.	NULL

Mutational	NULL
definition	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Rev	NULL
activation	NULL
domain	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

6514248-4254	NULL
.	NULL

Mancuso	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
T.	NULL
J	NULL
.	NULL

Hope	NULL
,	NULL
L.	NULL
Zhu	NULL
,	NULL
D.	NULL
Derse	NULL
,	NULL
T.	NULL
Phillips	NULL
,	NULL
and	NULL
T.	NULL
G.	NULL
Parslow	NULL
.	NULL

1994	NULL
.	NULL

Posttranscriptional	NULL
effector	NULL
domains	NULL
in	NULL
the	NULL
Rev	NULL
proteins	NULL
of	NULL
feline	NULL
immunodeficiency	NULL
virus	NULL
and	NULL
equine	NULL
infectious	NULL
anemia	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68	NULL
:	NULL
1998-2001	NULL
.	NULL

Meyer	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
and	NULL
M.	NULL
H.	NULL
Malim	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
HIV-1	NULL
Rev	NULL
#	NULL
rens-activator	NULL
shuttles	NULL
between	NULL
the	NULL
nucleus	NULL
and	NULL
the	NULL
cytoplasm	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:1538-1547	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

NOTES	NULL
6445	NULL
Meyer	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
J.	NULL
L.	NULL
Meinkoth	NULL
,	NULL
and	NULL
M.	NULL
H.	NULL
Malim	NULL
.	NULL

1996	NULL
.	NULL

Nuclear	NULL
transport	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
visna	NULL
virus	NULL
,	NULL
and	NULL
equine	NULL
infectious	NULL
anemia	NULL
virus	NULL
Rev	NULL
proteins	NULL
:	NULL
identification	NULL
of	NULL
a	NULL
family	NULL
of	NULL
transferable	NULL
nuclear	NULL
export	NULL
signals	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:2350-2359.	NULL
.	NULL

Parslow	NULL
,	NULL
T.	NULL
G.	NULL
1993	NULL
.	NULL

Post-transcriptional	NULL
regulation	NULL
of	NULL
human	NULL
retroviral	NULL
gene	NULL
expression	NULL
,	NULL
p.	NULL
101-136	NULL
.	NULL

In	NULL
B.	NULL
R.	NULL
Cullen	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Human	NULL
retroviruses	NULL
.	NULL

Oxford	NULL
University	NULL
Press	NULL
,	NULL
Oxford	NULL
.	NULL

Pifiol-Roma	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
G.	NULL
Dreyfuss	NULL
.	NULL

1992	NULL
.	NULL

Shuitling	NULL
of	NULL
pre-mRNA	NULL
binding	NULL
proteins	NULL
between	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
355:730-732	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
A.	NULL
F.	NULL
Gazdar	NULL
,	NULL
P.	NULL
A.	NULL
Bunn	NULL
,	NULL
J.	NULL
D.	NULL
Minna	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1980	NULL
.	NULL

Detection	NULL
and	NULL
isolation	NULL
of	NULL
type	NULL
C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
and	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:7415-7419	NULL
.	NULL

Richard	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Iacampo	NULL
,	NULL
and	NULL
A.	NULL
Cochrane	NULL
.	NULL

1994	NULL
.	NULL

HIV-1	NULL
Rev	NULL
is	NULL
capable	NULL
of	NULL
shuttling	NULL
between	NULL
the	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
.	NULL

Virology	NULL
204:123-131	NULL
.	NULL

Rimsky	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Duc	NULL
Dodon	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Transdominant	NULL
inactivation	NULL
of	NULL
HTLV-I	NULL
and	NULL
HIV-1	NULL
gene	NULL
expression	NULL
by	NULL
mutation	NULL
of	NULL
the	NULL
HTLV-I	NULL
Rex	NULL
transactivator	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
341:453-456	NULL
.	NULL

Ruhl	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Himmelspach	NULL
,	NULL
G.	NULL
M.	NULL
Bahr	NULL
,	NULL
F.	NULL
Hammerschmid	NULL
,	NULL
H.	NULL
Jaksche	NULL
,	NULL
B.	NULL
Wolff	NULL
,	NULL
H.	NULL
Aschauer	NULL
,	NULL
G.	NULL
K.	NULL
Farrington	NULL
,	NULL
H.	NULL
Probst	NULL
,	NULL
D.	NULL
Bevec	NULL
,	NULL
and	NULL
J.	NULL
Hauber	NULL
.	NULL

1993	NULL
.	NULL

Eukaryotic	NULL
initiation	NULL
factor	NULL
5A	NULL
is	NULL
a	NULL
cellular	NULL
target	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Rev	NULL
activation	NULL
domain	NULL
mediating	NULL
frans-activa-tion	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

123:1309-1320	NULL
.	NULL

Sakai	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Shibata	NULL
,	NULL
T.	NULL
Miura	NULL
,	NULL
M.	NULL
Hayami	NULL
,	NULL
K.	NULL
Ogawa	NULL
,	NULL
T.	NULL
Kiyomasu	NULL
,	NULL
A.	NULL
Ishimoto	NULL
,	NULL
and	NULL
A.	NULL
Adachi	NULL
.	NULL

1990	NULL
.	NULL

Complementation	NULL
of	NULL
the	NULL
rev	NULL
gene	NULL
mutation	NULL
among	NULL
human	NULL
and	NULL
simian	NULL
lentiviruses	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2202-2207	NULL
.	NULL

Siomi	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
Shida	NULL
,	NULL
S.	NULL
H.	NULL
Nam	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
M.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
Hatanaka	NULL
.	NULL

1988	NULL
.	NULL

Sequence	NULL
requirements	NULL
for	NULL
nucleolar	NULL
localization	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
pX	NULL
protein	NULL
,	NULL
which	NULL
regulates	NULL
viral	NULL
RNA	NULL
processing	NULL
.	NULL

Cell	NULL
55:197-209	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
W.	NULL
C.	NULL
Goh	NULL
,	NULL
C.	NULL
Rosen	NULL
,	NULL
A.	NULL
Dayton	NULL
,	NULL
E.	NULL
Terwilliger	NULL
,	NULL
and	NULL
W.	NULL
Hasel-tine	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
second	NULL
post-transcriptional	NULL
frems-activator	NULL
gene	NULL
required	NULL
for	NULL
HTLV-II	NULL
replication	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
321:412-417	NULL
.	NULL

Stauber	NULL
,	NULL
R.	NULL
,	NULL
G.	NULL
A.	NULL
Gaitanaris	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Pavlakis	NULL
.	NULL

1995	NULL
.	NULL

Analysis	NULL
of	NULL
trafficking	NULL
of	NULL
Rev	NULL
and	NULL
transdominant	NULL
Rev	NULL
proteins	NULL
in	NULL
living	NULL
cells	NULL
using	NULL
green	NULL
fluorescent	NULL
protein	NULL
fusions	NULL
:	NULL
transdominant	NULL
Rev	NULL
blocks	NULL
the	NULL
export	NULL
of	NULL
Rev	NULL
from	NULL
the	NULL
nucleus	NULL
to	NULL
the	NULL
cytoplasm	NULL
.	NULL

Virology	NULL
213:439-449	NULL
.	NULL

Stutz	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
Neville	NULL
,	NULL
and	NULL
M.	NULL
Rosbash	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
novel	NULL
nuclear	NULL
pore-associated	NULL
protein	NULL
as	NULL
a	NULL
functional	NULL
target	NULL
of	NULL
the	NULL
HIV-1	NULL
Rev	NULL
protein	NULL
in	NULL
yeast	NULL
.	NULL

Cell	NULL
82:495-506	NULL
.	NULL

Tiley	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
P.	NULL
H.	NULL
Brown	NULL
,	NULL
S.-Y	NULL
.	NULL

Le	NULL
,	NULL
J.	NULL
V.	NULL
Maizel	NULL
,	NULL
J.	NULL
E.	NULL
Clements	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Cullen	NULL
.	NULL

1990	NULL
.	NULL

Visna	NULL
virus	NULL
encodes	NULL
a	NULL
post-transcriptional	NULL
regulator	NULL
of	NULL
viral	NULL
structural	NULL
gene	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:7497-7501	NULL
.	NULL

Toohey	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Haase	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
rev	NULL
gene	NULL
of	NULL
visna	NULL
virus	NULL
is	NULL
required	NULL
for	NULL
productive	NULL
infection	NULL
.	NULL

Virology	NULL
200:276-280	NULL
.	NULL

Unge	NULL
,	NULL
T.	NULL
,	NULL
L.	NULL
Solomin	NULL
,	NULL
M.	NULL
Mellini	NULL
,	NULL
D.	NULL
Derse	NULL
,	NULL
B.	NULL
K.	NULL
Felber	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Pavlakis	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
Rex	NULL
regulatory	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
binds	NULL
specifically	NULL
to	NULL
its	NULL
target	NULL
site	NULL
within	NULL
the	NULL
viral	NULL
RNA	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:7145-7149	NULL
.	NULL

Weichselbraun	NULL
,	NULL
L	NULL
,	NULL
G.	NULL
K.	NULL
Farrington	NULL
,	NULL
J.	NULL
R.	NULL
Rusche	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
J.	NULL
Hauber	NULL
.	NULL

1992	NULL
.	NULL

Definition	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Rev	NULL
and	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Rex	NULL
protein	NULL
activation	NULL
domain	NULL
by	NULL
functional	NULL
exchange	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:2583-2587	NULL
.	NULL

Wen	NULL
,	NULL
W.	NULL
,	NULL
J.	NULL
L.	NULL
Meinkoth	NULL
,	NULL
R.	NULL
Y.	NULL
Tsien	NULL
,	NULL
and	NULL
S.	NULL
S.	NULL
Taylor	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
signal	NULL
for	NULL
rapid	NULL
export	NULL
of	NULL
proteins	NULL
from	NULL
the	NULL
nucleus	NULL
.	NULL

Cell	NULL
82:463-473	NULL
.	NULL

